Long-Term Survival with Primary Glioblastoma Multiforme: A Clinical Study in Bulgarian Patients

Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor with an extremely poor prognosis in spite of multimodal treatment approaches. The estimated median survival in cases with GBM is about 12–16 months. Those patients who survive =3 years after the initial diagnosis are...

Descripción completa

Detalles Bibliográficos
Autores principales: Naydenov, E., Tzekov, C., Minkin, K., Nachev, S., Romansky, K., Bussarsky, V.
Formato: Texto
Lenguaje:English
Publicado: S. Karger AG 2011
Materias:
Published: January 2011
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085065/
https://www.ncbi.nlm.nih.gov/pubmed/21537375
http://dx.doi.org/10.1159/000323432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085065/
https://www.ncbi.nlm.nih.gov/pubmed/21537375
http://dx.doi.org/10.1159/000323432

Ejemplares similares